Word

XL-PROTEIN

Status

Registered

Status Code

700

Status Date

Tuesday, January 18, 2022

Serial Number

79289202

Registration Number

6617137

Registration Date

Tuesday, January 18, 2022

Mark Type

4000

Filing Date

Monday, May 18, 2020

Published for Opposition

Tuesday, November 2, 2021

Trademark Owner History

XL-protein GmbH - Original Registrant

Classifications

5 Pharmaceutical, medical and veterinary preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases or bone diseases; Pharmaceutical preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases and diagnostic reagents for use in medicine and dentistry; Test kit reagents for use in medicine and dentistry; Chemical, biochemical and biotechnological preparations for medical and diagnostic use, namely reagents for medical purposes and solvents for sample preparation, modification and manipulation of cells as well as for use in methods for labeling, separation, isolation, purification, multiplication and analysis of biopolymers, especially nucleic acids, proteins, macromolecules and biologically active substances for medical diagnostic use; Drugs for preventive, curative and palliative purposes, namely for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Diagnostic medical biomarkers, especially for preventive, diagnostic, prognostic or predictive use; Medical preparations, namely, kits for use in medical laboratories, especially for preventive, diagnostic, prognostic or predictive use composed of proteinaceous reagents for medical purposes; Biomolecules for medical use, namely, for binding of active agents in the field of treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Medical preparations for use in medical diagnostic for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Chemical and biological preparations for medical and diagnostic purposes for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases

1 Chemical and biochemical preparations for use in biochemical research laboratories, in chemical research laboratories, in biotechnological research laboratories or in pharmaceutical research laboratories, other than for medical and veterinary use, as well as for industrial and scientific use

42 Scientific and technological services and research, namely, scientific research, analysis, and testing, and research all in the field of chemistry, genetics, biology, biotechnology and biochemistry; Medical or scientific laboratory services, namely, testing services in the field of DNA, RNA as well as protein expression, detection and analysis and design relating thereto, especially in the field of chemistry, genetics, biology, biotechnology and biochemistry; Services of a chemical and biochemical scientific or medical laboratory; Technological services, namely, technical processing in the nature of product development and technical scientific analysis of biomaterials and medically relevant data especially for scientific and industrial research

Trademark Events

Jul 18, 2022

Final Decision Transaction Processed By Ib

Jun 27, 2022

Final Disposition Notice Sent To Ib

Jun 27, 2022

Final Disposition Processed

Apr 18, 2022

Final Disposition Notice Created, To Be Sent To Ib

Jan 18, 2022

Registered-Principal Register

Jan 1, 2022

Notification Of Possible Opposition - Processed By Ib

Dec 15, 2021

Notification Of Possible Opposition Sent To Ib

Dec 15, 2021

Notification Of Possible Opposition Created, To Be Sent To Ib

Nov 8, 2021

Notification Processed By Ib

Nov 2, 2021

Official Gazette Publication Confirmation E-Mailed

Nov 2, 2021

Published For Opposition

Oct 13, 2021

Notification Of Possible Opposition Sent To Ib

Oct 13, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Oct 13, 2021

Notification Of Notice Of Publication E-Mailed

Sep 29, 2021

Approved For Pub - Principal Register

Sep 28, 2021

Teas/Email Correspondence Entered

Sep 28, 2021

Correspondence Received In Law Office

Sep 28, 2021

Teas Request For Reconsideration Received

Mar 30, 2021

Notification Of Final Refusal Emailed

Mar 30, 2021

Final Refusal E-Mailed

Mar 30, 2021

Final Refusal Written

Mar 10, 2021

Teas/Email Correspondence Entered

Mar 9, 2021

Correspondence Received In Law Office

Mar 9, 2021

Teas Response To Office Action Received

Oct 4, 2020

Refusal Processed By Ib

Sep 14, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Sep 14, 2020

Refusal Processed By Mpu

Aug 18, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Aug 17, 2020

Non-Final Action Written

Aug 14, 2020

Assigned To Examiner

Jul 14, 2020

Application Filing Receipt Mailed

Jul 10, 2020

New Application Office Supplied Data Entered In Tram

Jul 9, 2020

Sn Assigned For Sect 66a Appl From Ib